Primary prevention of gynecologic cancers
- PMID: 7847546
- DOI: 10.1016/0002-9378(95)90125-6
Primary prevention of gynecologic cancers
Abstract
A shift from treatment to prevention of the three major gynecologic cancers is overdue. The traditional approach to cervical, endometrial, and ovarian cancers has been secondary or tertiary prevention--early detection and treatment or mitigation of damage, respectively. We reviewed the literature on these cancers to identify strategies for primary prevention. Cervical cancer behaves as a sexually transmitted disease. As with other such diseases, barrier and spermicidal contraceptives lower the risk of cervical cancer; the risk reduction approximates 50%. Combination oral contraceptives help prevent both endometrial and epithelial ovarian cancers. The risk of endometrial cancer among former oral contraceptive users is reduced by about 50% and that of ovarian cancer by about 30% to 60%. Weight control confers strong protection against endometrial cancer. Breast-feeding and tubal sterilization also appear to protect against ovarian cancer. Although women have a range of practical, effective measures available to reduce their risk of these cancers, few are aware of them. Without this information, women cannot make fully informed decisions about their health.
Similar articles
-
Oral contraceptives and gynecologic cancer: an update for the 1990s.Am J Obstet Gynecol. 1992 Oct;167(4 Pt 2):1171-6. doi: 10.1016/s0002-9378(12)90407-x. Am J Obstet Gynecol. 1992. PMID: 1415442 Review.
-
Update on cancer control in women.Int J Gynaecol Obstet. 2000 Aug;70(2):263-303. doi: 10.1016/s0020-7292(00)00298-8. Int J Gynaecol Obstet. 2000. PMID: 10960611
-
Physical activity and gynecologic cancer prevention.Recent Results Cancer Res. 2011;186:159-85. doi: 10.1007/978-3-642-04231-7_7. Recent Results Cancer Res. 2011. PMID: 21113764 Review.
-
The pill and gynecologic cancer: controversy and mystery prevail.J Med Assoc Ga. 1995 Sep;84(7):320-2. J Med Assoc Ga. 1995. PMID: 7561539
-
The prevention of breast cancer through reduced ovarian steroid exposure.Acta Oncol. 1992;31(2):167-74. doi: 10.3109/02841869209088898. Acta Oncol. 1992. PMID: 1622631 Review.
Cited by
-
Author's response.West J Med. 2000 Jul;173(1):12-3. doi: 10.1136/ewjm.173.1.12-a. West J Med. 2000. PMID: 10903278 Free PMC article. No abstract available.
-
State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Int J Pediatr Endocrinol. 2011 Aug 26;2011(1):9. doi: 10.1186/1687-9856-2011-9. Int J Pediatr Endocrinol. 2011. PMID: 21899727 Free PMC article.
-
The use of oral contraceptive before pregnancy and breastfeeding duration: a cross-sectional study with retrospective ascertainment.Int Breastfeed J. 2008 Dec 16;3:29. doi: 10.1186/1746-4358-3-29. Int Breastfeed J. 2008. PMID: 19087336 Free PMC article.
-
Noncontraceptive health benefits of oral contraceptives.Rev Endocr Metab Disord. 2002 Sep;3(3):277-83. doi: 10.1023/a:1020084728544. Rev Endocr Metab Disord. 2002. PMID: 12215722 Review. No abstract available.
-
Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.Cancer Res. 2010 Aug 1;70(15):6225-32. doi: 10.1158/0008-5472.CAN-10-0149. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631067 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
